Aug 01, 2025 • Motley Fool
BULLISH
Waystar ( WAY ) Q2 Revenue Jumps 15%
Waystar ( NASDAQ:WAY ) , a leading provider of cloud-based healthcare payment software, reported second quarter 2025 earnings results on July 30, 2025. The main news: GAAP revenue climbed to $270.7 million in Q2 2025, exceeding consensus estimates by $11.17 million, and non-GAAP earnings per ...
Jul 30, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Compared to Estimates, Waystar ( WAY ) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Waystar (WAY) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Jul 30, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Waystar Holding ( WAY ) Q2 Earnings Top Estimates
Waystar (WAY) delivered earnings and revenue surprises of +9.09% and -0.13%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Jul 24, 2025 • Benzinga
SOMEWHAT-BULLISH
AI-Focused Waystar, Iodine Deal Wins Praise For Margin Upside - Waystar Holding ( NASDAQ:WAY )
Waystar to acquire Iodine Software for $1.25 billion, expanding TAM by over 15% and boosting AI-powered healthcare payment tools Q2 2025 revenue expected at $271 million, EBITDA margins seen improving post-deal.
Jul 23, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Waystar Holding ( WAY ) Earnings Expected to Grow: Should You Buy?
Waystar (WAY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Jul 21, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Calix ( CALX ) Q2 Earnings and Revenues Top Estimates
Calix (CALX) delivered earnings and revenue surprises of +65.00% and +8.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?